You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BIOMEA FUSION INC

Biomea Fusion Inc

XNAS: BMEA

Download real time

1.75 0.02 (1.16%)

New 52W Low in past week

396.8K XNAS Volume

XNAS 11 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
6S
14W
0O
3T
65.8

Market Cap

Below industry Median
-0.5

PE TTM

Negative PE TTM
0

PEG TTM

1.3

Price to Book

Below industry Median
0.3

Beta 1Year

Very Low volatility


Insider Trading disclosures for Biomea Fusion Inc

The latest disclosure was made by Michael J. M. Hitchcock in Biomea Fusion Inc where a trade of 350,000 Stock Option (Right to Buy) done was reported to US exchanges on March 26, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael J. M. Hitchcock Director, Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 350,000 350,000 - - Stock Option (Right to Buy)
Franco Valle Chief Financial Officer 30 Nov 2024 495 42,995 - 6.2 3,046 Common Stock
Michael J. M. Hitchcock Director Purchase of securities on an exchange or from another person at price $ 10.06 per share. 30 Sep 2024 10,000 15,000 - 10.1 100,600 Common Stock
Michael J. M. Hitchcock Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 51,025 51,025 - - Stock Option (Right to Buy)
Bihua Chen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 51,025 51 - - Stock Option (right to buy)
Sumita Ray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 51,025 51,025 - - Stock Option (Right to Buy)
Elizabeth Faust Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 51,025 51,025 - - Stock Option (Right to Buy)
Eric Aguiar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 51,025 51,025 - - Stock Option (Right to Buy)
Franco Valle Chief Financial Officer 11 Jun 2024 12,509 42,500 - 4.4 55,361 Common Stock
Franco Valle Chief Financial Officer 11 Jun 2024 4,448 29,991 - 3.8 16,825 Common Stock
Juan Pablo Frias Chief Medical Officer Grant, award, or other acquisition of securities at price $ 8.94 per share. 31 May 2024 349 349 - 8.9 3,121 Common Stock
Rainer Erdtmann M. Director, President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2024 135,700 135,700 - - Stock Option (Right to Buy)
Valle Franco Chief Financial Officer 17 Jan 2024 145,245 145,245 - - Stock Option (Right to Buy)
Juan Pablo Frias Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2024 111,090 111,090 - - Stock Option (Right to Buy)
Andrew Thomas Butler Director, Chief Executive Officer, Ten Percent Owner 17 Jan 2024 407,502 407,502 - - Stock Option (Right to Buy)
Franco Valle Chief Financial Officer 31 May 2023 4,273 24,198 - 3.8 16,163 Common Stock
Bihua Chen Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 30.00 per share. 30 Mar 2023 400,000 3,570,872 - 30 12,000,000 Common Stock
Thomas Andrew Butler Director, Chief Executive Officer, Ten Percent Owner 06 Jan 2023 354,350 354,350 - - Stock Option (Right to Buy)
Franco Valle Chief Financial Officer 06 Jan 2023 126,300 126,300 - - Stock Option (Right to Buy)
Rainer M. Erdtmann Director, President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 118,000 118,000 - - Stock Option (Right to Buy)
Franco Valle Chief Financial Officer 30 Nov 2022 2,518 19,925 - 3.8 9,524 Common Stock
Michael J. M. Hitchcock Director Purchase of securities on an exchange or from another person at price $ 7.93 per share. 14 Nov 2022 5,000 5,000 - 7.9 39,650 Common Stock
Franco Valle Chief Financial Officer 11 Nov 2022 4,100 17,407 - 7.6 31,286 Common Stock
Michael J. M. Hitchcock Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 23,867 23,867 - - Stock Option (Right to Buy)
Bihua Chen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 23,867 23,867 - - Stock Option (right to buy)
Sumita Ray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 23,867 23,867 - - Stock Option (Right to Buy)
Elizabeth Faust Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 45,755 45,755 - - Stock Option (Right to Buy)
Eric Aguiar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 23,867 23,867 - - Stock Option (Right to Buy)
Franco Valle Chief Financial Officer 31 May 2022 3,307 13,307 - 4.7 15,432 Common Stock
Sumita Ray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 21,461 21,461 - - Stock Option (Right to Buy)
Franco Valle Chief Financial Officer 14 Jan 2022 10,000 10,000 - 8.7 86,767 Common Stock
Sotirios Stergiopoulos Director Purchase of securities on an exchange or from another person at price $ 10.96 per share. 17 Sep 2021 34,658 4,400,000 - 11.0 379,852 Common Stock
Rainer M. Erdtmann Director, President & COO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.20 per share. 23 Aug 2021 24,000 228,470 - 13.2 316,872 Common Stock
Thomas Andrew Butler Director, CEO, Ten Percent Owner 23 Aug 2021 24,000 228,470 - 13.2 316,872 Common Stock
Franco Valle Chief Financial Officer 03 Aug 2021 165,000 165,000 - - Stock Option (Right to Buy)
Sumita Ray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 17,724 17,724 - - Stock Option (Right to Buy)
Bihua Chen Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 20 Apr 2021 900,000 3,170,872 - 17 15,300,000 Common Stock
Bihua Chen Director 20 Apr 2021 2,270,872 0 - - Series A Convertible Preferred Stock
Bihua Chen Director 20 Apr 2021 2,270,872 2,270,872 - - Common Stock
Thomas Andrew Butler Director, CEO, Ten Percent Owner 15 Apr 2021 176,470 176,470 - 17 2,999,990 Common Stock
Thomas Andrew Butler Director, CEO, Ten Percent Owner 15 Apr 2021 14,000 190,470 - 10.8 151,067 Common Stock
Thomas Andrew Butler Director, CEO, Ten Percent Owner 15 Apr 2021 14,000 204,470 - 10.8 150,738 Common Stock
Eric Aguiar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2021 28,911 28,911 - - Stock Option (Right to Buy)
Rainer M. Erdtmann Director, President & COO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 17.00 per share. 15 Apr 2021 176,470 176,470 - 17 2,999,990 Common Stock
Rainer M. Erdtmann Director, President & COO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.77 per share. 15 Apr 2021 14,000 204,470 - 10.8 150,738 Common Stock
Rainer M. Erdtmann Director, President & COO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.79 per share. 15 Apr 2021 14,000 190,470 - 10.8 151,067 Common Stock
Michael J. M. Hitchcock Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2021 28,911 28,911 - - Stock Option (Right to Buy)
Sotirios Stergiopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2021 28,911 28,911 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters